Moderna Stock Is Top S&P Performer After Miserable 2023. Why This Year Could Be Better.


Shares of Covid-19 vaccine maker Moderna were on track for their best single-day performance in more than a year, after an analyst at Oppenheimer issued a rare upgrade of the stock.

Continue reading this article with a Barron’s subscription.

View Options

Signup bonus from $125 to $3000 | Signup now Football & Online Casino

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

You Might Also Like: